Amperometric and Conductimetric Methods for Simultaneous Determination of Captopril and Bendroflumethiazide
- 31 December 1984
- journal article
- research article
- Published by Taylor & Francis in Analytical Letters
- Vol. 18 (20), 2591-2603
- https://doi.org/10.1080/00032718508064489
Abstract
The mixture of captopril (antihypertensive) and bendroflumethiazide (diuretic) was assayed using conductimetric and amperometric methods. Each method was applied for the analysis of laboratory-made sample mixtures in authentic and dosage forms. For captopril, the amperometric and conductimetric methods gave mean percent recoveries of 100.2 .+-. 1.2 and 99.6 .+-. 1.2, respectively. These results have shown good agreement when compared with other methods in the literature. When applied to bendroflumethiazide the conductimetric method gave percent recovery of 98.5 .+-. 1.6 which agreed closely with the spectrophotometric pharmacopoeial method. The pK1 for captopril was determined potentiometrically at room temperature (25.degree. C) in aqueous medium. The calculated value, based on Henderson equation was 3.78.This publication has 19 references indexed in Scilit:
- High-Performance Liquid Chromatographic Analysis of Captopril in PlasmaJournal of Pharmaceutical Sciences, 1981
- Determination of captopril in blood and urine by high-performance liquid chromatography.CHEMICAL & PHARMACEUTICAL BULLETIN, 1981
- Gas chromatography/selected ion monitoring mass spectrometric determination of captopril in human bloodAnalytical Chemistry, 1980
- Determinatin of captopril in biological fluids by gas-liquid chromatographyJournal of Chromatography A, 1980
- Thin-Layer Radiochromatographic Determination of Captopril (SQ 14,225) and its Disulfide Dimer Metabolite in BloodJournal of Liquid Chromatography, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- Angiotensin Converting-Enzyme Inhibitor in Refractory HypertensionNew England Journal of Medicine, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acidsBiochemistry, 1977
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977